Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The choice between medications should rest primarily on efficacy data, tolerability, availability, and cost rather than the B12 inclusion, which is valuable in both formulations
Given that obesity worsens MS outcomes and accelerates disease progression, weight management is particularly important for people living with MS
It's an exhausting, demoralizing process that stands between you and the treatment you need
Roche Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living with Overweight and Obesity
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
